Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special

CLNN Insider Trading (Clene)

Insider Ownership Percentage: 21.20%
Insider Buying (Last 12 Months): $1,999,996.92
Insider Selling (Last 12 Months): $0.00

Clene Insider Trading History Chart

This chart shows the insider buying and selling history at Clene by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Clene Share Price & Price History

Current Price: $4.73
Price Change: Price Decrease of -0.18 (-3.67%)
As of 11/26/2021 01:00 AM ET

This chart shows the closing price history over time for CLNN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special

Clene Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/24/2021David J. MatlinDirectorBuy207,684$9.63$1,999,996.9232,393View SEC Filing Icon  
See Full Table
Insider Trading at Clene?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Clene and related companies.

SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)

7.46% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CLNN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Clene Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2021American International Group Inc.10,735$73K0.0%-16.3%0.017%Search for SEC Filing on Google Icon
11/18/2021Bank of New York Mellon Corp61,036$0.42M0.0%+6.7%0.098%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System12,238$84K0.0%-61.3%0.020%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley20,979$0.14M0.0%+47.5%0.034%Search for SEC Filing on Google Icon
11/15/2021Penserra Capital Management LLC5,154$35K0.0%-35.9%0.008%Search for SEC Filing on Google Icon
11/12/2021Laird Norton Trust Company LLC268,581$1.83M0.2%+7.6%0.437%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC405,737$2.77M0.0%+0.8%0.660%Search for SEC Filing on Google Icon
11/9/2021Morgan Jess S & Co. Inc.29,750$0.20M0.1%N/A0.048%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,065,726$7.28M0.0%-9.5%1.733%Search for SEC Filing on Google Icon
11/9/2021Soltis Investment Advisors LLC218,920$1.50M0.2%N/A0.356%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG11,284$77K0.0%-16.9%0.018%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund12,560$86K0.0%-35.9%0.020%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley14,227$0.16M0.0%+575.9%0.023%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN13,000$0.15M0.0%+9,823.7%0.021%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC13,276$0.15M0.0%-21.6%0.022%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE5,859$66K0.0%+7,045.1%0.010%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System31,590$0.36M0.0%N/A0.051%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley14,227$0.16M0.0%+575.9%0.023%Search for SEC Filing on Google Icon
8/16/2021Pinz Capital Management LP6,292$71K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.147,392$1.66M0.0%+53.0%0.240%Search for SEC Filing on Google Icon
8/16/2021State Street Corp278,619$3.13M0.0%N/A0.453%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC54,870$0.62M0.0%N/A0.089%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp82,770$0.93M0.0%+105.7%0.135%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC402,395$4.52M0.0%+82.6%0.655%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,132,082$12.73M0.0%+9.3%1.844%Search for SEC Filing on Google Icon
8/12/2021Kepos Capital LP550,000$6.18M0.5%+175.0%0.896%Search for SEC Filing on Google Icon
8/12/2021Penserra Capital Management LLC8,043$90K0.0%+37.7%0.013%Search for SEC Filing on Google Icon
8/12/2021State of Wisconsin Investment Board15,626$0.18M0.0%N/A0.025%Search for SEC Filing on Google Icon
8/12/2021Legal & General Group Plc2,223$25K0.0%N/A0.004%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.8,785$99K0.0%N/A0.014%Search for SEC Filing on Google Icon
8/12/2021The Manufacturers Life Insurance Company13,393$0.15M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp57,228$0.64M0.0%N/A0.093%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.1,177,265$13.23M0.0%+2,071.4%1.918%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG13,585$0.15M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/5/2021Rhumbline Advisers15,031$0.17M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund19,600$0.22M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/2/2021SRS Capital Advisors Inc.52,250$0.59M0.1%N/A0.085%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.5,000$56K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC30,676$0.39M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC130,068$1.66M0.0%N/A0.218%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley2,105$27K0.0%+110.5%0.004%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC46,163$0.59M0.0%N/A0.077%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC118,533$1.52M0.1%N/A0.199%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.13,593$0.17M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/13/2021Laird Norton Trust Company LLC249,561$3.19M0.4%N/A0.419%Search for SEC Filing on Google Icon
5/13/2021Penserra Capital Management LLC5,840$74K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/13/2021Kepos Capital LP200,000$2.56M0.2%-24.0%0.336%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.10,646$0.14M0.0%N/A0.018%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp40,246$0.51M0.0%N/A0.068%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC220,355$2.82M0.0%N/A0.370%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.54,217$0.69M0.0%N/A0.091%Search for SEC Filing on Google Icon
4/27/2021Harel Insurance Investments & Financial Services Ltd.34,911$1.49M0.0%N/A1.010%Search for SEC Filing on Google Icon
2/16/2021Walleye Trading LLC15,909$0.14M0.0%N/A0.460%Search for SEC Filing on Google Icon
2/12/2021Basso Capital Management L.P.3,239$29K0.0%N/A0.094%Search for SEC Filing on Google Icon
2/12/2021Kepos Capital LP263,235$2.37M0.2%N/A7.617%Search for SEC Filing on Google Icon
2/10/2021Bluefin Capital Management LLC15,378$0.14M0.0%N/A0.445%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Clene logo
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson's; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company's products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat disease-causing infections, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. Clene Inc. is headquartered in Salt Lake City, Utah.
Read More on Clene

Today's Range

Now: $4.73
Low: $4.66
High: $5.01

50 Day Range

MA: $5.96
Low: $4.73
High: $7.53

52 Week Range

Now: $4.73
Low: $3.89
High: $17.82

Volume

71,929 shs

Average Volume

274,320 shs

Market Capitalization

$294.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Clene?

Clene's top insider shareholders include:
  1. David J Matlin (Director)

Who are the major institutional investors of Clene?

Clene's top institutional shareholders include:
  1. BlackRock Inc. — 1.73%
  2. Geode Capital Management LLC — 0.66%
  3. Laird Norton Trust Company LLC — 0.44%
  4. Soltis Investment Advisors LLC — 0.36%
  5. Bank of New York Mellon Corp — 0.10%
  6. Morgan Jess S & Co. Inc. — 0.05%

Which institutional investors are selling Clene stock?

Within the last quarter, CLNN stock was sold by these institutional investors:
  1. BlackRock Inc.
  2. California State Teachers Retirement System
  3. New York State Common Retirement Fund
  4. Penserra Capital Management LLC
  5. Deutsche Bank AG
  6. American International Group Inc.

Which institutional investors are buying Clene stock?

During the last quarter, CLNN stock was acquired by institutional investors including:
  1. Soltis Investment Advisors LLC
  2. Morgan Jess S & Co. Inc.
  3. Belvedere Trading LLC
  4. Laird Norton Trust Company LLC
  5. Morgan Stanley
  6. Bank of New York Mellon Corp
  7. Geode Capital Management LLC
Black Friday Special: Could 12/1 be the most profitable event in crypto history?
Man voted "#1 Most Trusted Crypto Expert" shares his latest buy recommendation.
Click For Special